Academic Journals Database
Disseminating quality controlled scientific knowledge

Search Articles for "Erlotinib"

ADD TO MY LIST
 
EGFR Mutations Detection in Non-small Cell Lung Cancer Tissues by Real-time PCR and DNA Sequencing

Author(s): Yongwen LI | Hongyu LIU | Ying LI | Yuli WANG | Jing WANG | Jun CHEN | Qinghua ZHOU
Observation of Erlotinib in the Treatment of Elderly Patients with Advanced Non-small Cell Lung Cancer and COPD

Author(s): Qing MA | Li MA | Yan WANG | Fanlu MENG | Linglin ZOU | Huiling ZHANG
Erlotinib in Patients with Brain Metastases for Non-small Cell Lung Cancer

Author(s): Jiandong ZHANG | Xinshuang YU | Jinming YU
Role of erlotinib in first-line and maintenance treatment of advanced non-small-cell lung cancer

Author(s): Noemí Reguart | Andrés Felipe Cardona | Rafael Rosell
Intermittent Chemotherapy and Erlotinib for Nonsmokers or Light Smokers with Advanced Adenocarcinoma of the Lung: A Phase II Clinical Trial

Author(s): Matjaz Zwitter | Mirjana Rajer | Viljem Kovac | Izidor Kern | Martina Vrankar | Uros Smrdel
Preclinical Testing of Erlotinib in a Transgenic Alveolar Rhabdomyosarcoma Mouse Model

Author(s): Jinu Abraham | Laura D. Nelon | Courtney B. Kubicek | Aoife Kilcoyne | Sheila T. Hampton | Lee Ann Zarzabal | Francis J. Giles | Joel E. Michalek | Brian P. Rubin | Charles Keller
Erlotinib in the treatment of advanced pancreatic cancer

Author(s): Robin K Kelley | Andrew H Ko
Toxic risk of stereotactic body radiotherapy and concurrent helical tomotherapy followed by erlotinib for non-small-cell lung cancer treatment - case report

Author(s): Hsieh Chen-Hsi | Chang Hou-Tai | Lin Shih-Chiang | Chen Yu-Jen | Wang Li-Ying | Hsieh Yen-Ping | Chen Chien-An | Chong Ngot-Swan | Lin Shoei | Chen Chun-Yi | Shueng Pei-Wei
Recent progress and limitations of chemotherapy for pancreatic and biliary tract cancers

Author(s): Minoru Tada, Yousuke Nakai, Takashi Sasaki, Tsuyoshi Hamada, Rie Nagano, Dai Mohri, Koji Miyabayashi, Keisuke Yamamoto, Hirofumi Kogure, Kazumichi Kawakubo, Yukiko Ito, Natsuyo Yamamoto, Naoki Sasahira, Kenji Hirano, Hideaki Ijichi, Keishuke Tateishi, Hiroyuki Isayama, Masao Omata, Kazuhiko Koike
KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib

Author(s): Pao William | Wang Theresa Y | Riely Gregory J | Miller Vincent A | Pan Qiulu | Ladanyi Marc | Zakowski Maureen F | Heelan Robert T | Kris Mark G | Varmus Harold E
Recent advances of novel targeted therapy in non-small cell lung cancer

Author(s): Katzel Jed | Fanucchi Michael | Li Zujun
Current Surgical Aspects of Palliative Treatment for Unresectable Pancreatic Cancer

Author(s): Konstantinos Karapanos | Iakovos N. Nomikos
Targeted medical therapy of biliary tract cancer: Recent advances and future perspectives

Author(s): Michael Höpfner, Detlef Schuppan, Hans Scherübl
Erlotinib in the Second/Third Line Treatment of Patients with Advanced Non-small Cell Lung Cancer

Author(s): Yisheng HUANG | Jinji YANG | Yujuan HUANG | Chongrui XU | Qing ZHOU | Zhen WANG | Yilong WU
MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/Akt pathway and tumor growth in prostate cancer

Author(s): Qi Wenqing | Cooke Larry | Stejskal Amy | Riley Christopher | Croce Kimiko | Saldanha Jose | Bearss David | Mahadevan Daruka
Response to gefitinib and erlotinib in Non-small cell lung cancer: a retrospective study

Author(s): Emery Ivette | Battelli Chiara | Auclair Paul | Carrier Kathleen | Hayes Daniel
Erlotinib in the trentment of Advanced Non-small-cell Lung Cancer: A Systematic Review

Author(s): Lina ZHU | Zhenjun YANG | Shiyong WANG | Yanming TANG
A Systematic Review of Erlotinib for Advanced Non-small Cell Lung Cancer

Author(s): Huiling GUO | Rongfang ZHANG | Qimei YANG | Lingjuan ZHANG | Kehu YANG | Jinhui TIAN
The Impact of Smoking Status on the Efficacy of Erlotinib in Patients with Advanced Non-small Cell Lung Cancer

Author(s): Yisheng HUANG | Jinji YANG | Yan YANG | Yujuan HUANG | Riqiang LIAO | Yilong WU
Clinical Observation of Erlotinib in the Treatment of Advanced and Previously Treated Non-small Cell Lung Cancer

Author(s): Junfang TANG | Yunzhong ZHU | Zhe LIU | Wei WU | Zan LIU | Heling SHI | Qiyi MENG | Mingzhi LI | Yuhua WU | Liyan XU
Clinical Observation of Erlotinib as the First-line Treatment for Patients with Advanced Non-small Cell Lung Cancer

Author(s): Cheng HUANG | Biao WU | Wu ZHUANG | Zhenwu XU | Jing ZHANG | Yunjian HUANG
Clinical Study of Erlotinib in the Treatment of Patients with Advanced Stage Non-small Cell Lung Cancer

Author(s): Tongshan WANG | Jing SUN | Wen GAO | Hua SHEN | Xiaodong LI | Yongmei YIN | Yongqian SHU | Renhua GUO
Clinical Observation of Erlotinib in the Treatment of Advanced Non-small Cell Lung Cancer: A Report of 92 Eases

Author(s): Aiqin GU | Liwen XIONG | Huimin WANG | Chunlei SHI | Zhiqiang GAO | Baohui HAN
A Retrospective Study of Erlotinib in the Treatment of 70 Patients with Non-small Cell Lung Cancer

Author(s): Yuhua WU | Hong TAO | Junfang TANG | Xinyong ZHANG | Yunzhong ZHU | Zhe LIU | Heling SHI | Qiyi MENG | Wei WU | Zan LIU | Lili GUO | Mingzhi LI | Liyan XU
Application of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor as the First-line Therapy in Patients with Advanced Non-small Cell Lung Cancer

Author(s): Yang XU | Liang’an CHEN | Qing TIAN | Zhen YANG | Wei ZHAO | Ping WANG | Xingchen LIU | Chunsun LI
Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model

Author(s): Diaz Roque | Nguewa Paul | Parrondo Ricardo | Perez-Stable Carlos | Manrique Irene | Redrado Miriam | Catena Raul | Collantes Maria | Peñuelas Ivan | Díaz-González Juan | Calvo Alfonso
Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies

Author(s): Javle Milind | Shroff Rachna | Xiong Henry | Varadhachary Gauri | Fogelman David | Reddy Shrikanth | Davis Darren | Zhang Yujian | Wolff Robert | Abbruzzese James
Clinical implications of novel activating EGFR mutations in malignant peritoneal mesothelioma

Author(s): Foster Jason | Radhakrishna Uppala | Govindarajan Venkatesh | Carreau Joseph | Gatalica Zoran | Sharma Poonam | Nath Swapan | Loggie Brian
Small molecule tyrosine kinase inhibitors in pancreatic cancer

Author(s): Sachin Gupta | Bassel F El-Rayes
Phase II trial of second-line erlotinib and digoxin for nonsmall cell lung cancer (NSCLC)

Author(s): Fadi Kayali | Muhamad A Janjua | Damian A Laber | Donald Miller | Goetz H Kloecker
Erlotinib-associated Near-fatal Interstitial Pneumonitis in A Patient with Relapsed Lung Adenocarcinoma

Author(s): Chun-Liang Chou | How-Wen Ko | Chih-Wei Wang | Chih-Teng Yu | Han-Pin Kuo | Chien-Da Huang
Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer

Author(s): Peraldo-Neia Caterina | Migliardi Giorgia | Mello-Grand Maurizia | Montemurro Filippo | Segir Raffaella | Pignochino Ymera | Cavalloni Giuliana | Torchio Bruno | Mosso Luciano | Chiorino Giovanna | Aglietta Massimo
Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analysis

Author(s): Watanabe Satoshi | Tanaka Junta | Ota Takeshi | Kondo Rie | Tanaka Hiroshi | Kagamu Hiroshi | Ichikawa Kosuke | Koshio Jun | Baba Junko | Miyabayashi Takao | Narita Ichiei | Yoshizawa Hirohisa
Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas

Author(s): Pignochino Ymera | Sarotto Ivana | Peraldo-Neia Caterina | Penachioni Junia | Cavalloni Giuliana | Migliardi Giorgia | Casorzo Laura | Chiorino Giovanna | Risio Mauro | Bardelli Alberto | Aglietta Massimo | Leone Francesco
Current approach in the treatment of hepatocellular carcinoma

Author(s): Luigi Rossi | Federica Zoratto | Anselmo Papa | Francesca Iodice | Marina Minozzi | Luigi Frati | Silverio Tomao
Recent developments in palliative chemotherapy for locally advanced and metastatic pancreas cancer

Author(s): Soley Bayraktar, Ulas Darda Bayraktar, Caio Max Rocha-Lima
Retreatment with Epidermal Growth Factor Receptor Inhibitor After Initial Failure in Advanced Non-small Cell Lung Cancer

Author(s): Tongtong AN | Zhen HUANG | Yuyan WANG | Zhijie WANG | Hua BAI | Jie WANG
Anti-tumor activity of erlotinib in the BxPC-3 pancreatic cancer cell line

Author(s): Ying-Ying Lu, Da-Dao Jing, Ming Xu, Kai Wu, Xing-Peng Wang
Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain

Author(s): Pao William | Miller Vincent A | Politi Katerina A | Riely Gregory J | Somwar Romel | Zakowski Maureen F | Kris Mark G | Varmus Harold
Gene expression patterns that predict sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer cell lines and human lung tumors

Author(s): Balko Justin | Potti Anil | Saunders Christopher | Stromberg Arnold | Haura Eric | Black Esther
A novel mutation in the tyrosine kinase domain of ERBB2 in hepatocellular carcinoma

Author(s): Bekaii-Saab Tanios | Williams Nita | Plass Christoph | Calero Miguel | Eng Charis
A phase II trial of docetaxel and erlotinib as first-line therapy for elderly patients with androgen-independent prostate cancer

Author(s): Gross Mitchell | Higano Celestia | Pantuck Allan | Castellanos Olga | Green Erica | Nguyen Koo | Agus David
Fatal interstitial lung disease associated with oral erlotinib therapy for lung cancer

Author(s): Makris Demosthenes | Scherpereel Arnaud | Copin Marie | Colin Guillaume | Brun Luc | Lafitte Jean | Marquette Charles
Functional analysis of cancer-associated EGFR mutants using a cellular assay with YFP-tagged EGFR intracellular domain

Author(s): de Gunst Matheus | Gallegos-Ruiz Marielle | Giaccone Giuseppe | Rodriguez Jose
Erlotinib hydrochloride: an anticancer agent

Author(s): S. Selvanayagam | B. Sridhar | K. Ravikumar
The Relationship between EGFR Mutations and Response and Prognosis of Tyrosine Kinase Inhibitors in Advanced Non-small-cell Lung Cancer

Author(s): Xinyong ZHANG | Liyan XU | Hui WANG | Yunzhong ZHU | Zhe LIU | Wentao YUE | Junfang TANG | Wei WU | Zan LIU | Yuhua WU | Chunyan ZHANG | Yuankai SHI | Mengzhao WANG | Heling SHI | Mingzhi LI | Qiyi MENG | Lili GUO | Jinghui WANG | Xuebing LI
Synchronous Lung Cancers: When Same Histological Types Feature Different Molecular Profiles and Response Phenotypes

Author(s): Giulia M Stella, Francesca Cemmi, Simona Inghilleri, Michele Zorzetto, Maurizio Luisetti, Ernesto Pozzi
Successful Erlotinib Treatment for a Patient with Gefitinib-Related Hepatotoxicity and Lung Adenocarcinoma Refractory to Intermittently Administered Gefitinib

Author(s): Tatsuya Nagano | Yoshikazu Kotani | Kazuyuki Kobayashi | Masahiro Katsurada | Yukihisa Hatakeyama | Suya Hori | Daisuke Tamura | Daisuke Kasai | Yasuhiro Funada | Yoshihiro Nishimura
EGFR as a therapeutic target in glioblastoma

Author(s): David M Siebert | Sophia F Shakur | Peter Pytel | Lukas Rimas
Cross-market cost-effectiveness analysis of erlotinib as first-line maintenance treatment for patients with stable non-small cell lung cancer

Author(s): Vergnenègre A | Ray JA | Chouaid C | Grossi F | Bischoff HG | Heigener DF | Walzer S
Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model

Author(s): Beatriz Pagán | Angel A Isidro | Myrella L Cruz | Yuan Ren | Domenico Coppola | Jie Wu | Caroline B Appleyard
Successful Treatment of Recurrent Triple-Negative Breast Cancer with Combination of Targeted Therapies

Author(s): Stanislaw R. Burzynski | Alejandro Marquis | Eva Nagy-Kubove | Tomasz Janicki
Downregulation of E-Cadherin enhances proliferation of head and neck cancer through transcriptional regulation of EGFR

Author(s): Wang Dongsheng | Su Ling | Huang Donghai | Zhang Hongzheng | Shin Dong | Chen Zhuo
Clinical pharmacogenomic testing of KRAS, BRAF and EGFR mutations by high resolution melting analysis and ultra-deep pyrosequencing

Author(s): Borràs Emma | Jurado Ismael | Hernan Imma | Gamundi María | Dias Miguel | Martí Isabel | Mañé Begoña | Arcusa Àngels | Agúndez José | Blanca Miguel | Carballo Miguel
Efficacy of epidermal growth factor receptor targeting in advanced chordoma: case report and literature review

Author(s): Launay Simon | Chetaille Bruno | Medina Fanny | Perrot Delphine | Nazarian Serge | Guiramand Jérôme | Moureau-Zabotto Laurence | Bertucci François
mRNA expression levels and genetic status of genes involved in the EGFR and NF-κB pathways in metastatic non-small-cell lung cancer patients

Author(s): Santarpia Mariacarmela | Magri Ignacio | Sanchez-Ronco Maria | Costa Carlota | Molina-Vila Miguel | Gimenez-Capitan Ana | Bertran-Alamillo Jordi | Mayo Clara | Benlloch Susana | Viteri Santiago | Gasco Amaya | Mederos Nuria | Carcereny Enric | Taron Miquel | Rosell Rafael
Epidermal growth factor receptor and K-Ras in non-small cell lung cancer-molecular pathways involved and targeted therapies

Author(s): Ramon Andrade de Mello | Dânia Sofia Marques | Rui Medeiros | António MF Araújo
Pemetrexed Alone versus Pemetrexed Combined with Oxaliplatin as Salvage Therapy 
in Stage IV Lung Adenocarcinoma

Author(s): Youru LIU | Yinling JIANG | Zhiqiang GAO | Xiangying WANG | Baohui HAN | Liyan JIANG
Safety and pharmacokinetics of motesanib in combination with gemcitabine and erlotinib for the treatment of solid tumors: a phase 1b study

Author(s): Kotasek Dusan | Tebbutt Niall | Desai Jayesh | Welch Stephen | Siu Lillian | McCoy Sheryl | Sun Yu-Nien | Johnson Jessica | Adewoye Adeboye | Price Timothy
Gemcitabine Overcomes Erlotinib Resistance in EGFR-Overexpressing Cancer Cells through Downregulation of Akt

Author(s): Chandra Bartholomeusz, Fumiyuki Yamasaki, Hitomi Saso, Kaoru Kurisu, Gabriel N. Hortobagyi, Naoto T. Ueno
Targeting EGFR in Triple Negative Breast Cancer

Author(s): Naoto T. Ueno, Dongwei Zhang
Development and Validation of High Performance Liquid Chromatographic Method for the Determination of Erlotinib

Author(s): M.Padmalatha1, Dr. K. Vanitha Prakash2*, Syeda Kusum1, R.Vishnu kumar1, K.Wilson1 and V.Vivekananda1
Pancreatic adenocarcinoma-associated polymyositis treated with corticosteroids along with cancer specific treatment: case report

Author(s): Syrios John | Kechagias Georgios | Xynos Ioannis | Gamaletsou Maria | Papageorgiou Aristea | Agrogiannis George | Tsavaris Nicolas
The use of erlotinib in daily practice: a study on adherence and patients' experiences

Author(s): Timmers Lonneke | Boons Christel | Mangnus Dirk | Moes Josee | Swart Eleonora | Boven Epie | Smit Egbert | Hugtenburg Jacqueline
Inhibitory effect of flavonoids on mutant H-Rasp21 protein

Author(s): Tariq A. Masoodi | Adel H. Alhamdanz
Effectiveness of maintenance treatments for nonsmall cell lung cancer

Author(s): Eadens MJ | Robinson SI | Price KA
Affiliate Program      Why do you need a reservation system?